“Our goals were to define the incidence rate of catheter-related thrombosis in a hospitalized, noncritically ill, pediatric population and to determine modifiable factors that alter the risk of thrombosis” Smitherman et al (2015).
Smitherman, A.B., Alexander, T., Connelly, M., Snavely, A.C., Weston, B.W., Liles, E.A. and Steiner, M.J. (2015) The incidence of catheter-associated venous thrombosis in noncritically ill children. Hospital Pediatrics. 5(2), p.59-66.
OBJECTIVE: Previous studies estimated the incidence of catheter-associated venous thrombosis to be between 2% and 81%. Our goals were to define the incidence rate of catheter-related thrombosis in a hospitalized, noncritically ill, pediatric population and to determine modifiable factors that alter the risk of thrombosis.
METHODS: A retrospective cohort study was performed at the North Carolina Children’s Hospital from 2009 to 2012. Chart review was performed with extraction of patient characteristics and line-related variables. Presence of symptomatic catheter-associated venous thrombosis was the primary outcome. Bivariable analysis and multivariable logistic regression were used to explore associations between line-related variables and thrombosis.
RESULTS: A total of 1135 lines were placed in 815 patients for 118 023 catheter-days. Thirty-six were complicated by venous thrombosis (3.2%) yielding a rate of 0.3 events per 1000 catheter-days. In multivariable analysis, increasing age (odds ratio 1.08, 95% confidence interval 1.03-1.13; P = .002), renal dialysis (OR 3.2, 95% CI 1.09-9.66; P = .035), and a diagnosis of inflammatory bowel disease or short bowel syndrome (OR 4.3, 95% CI 1.2-15.0; P = .02) were associated with increased risk of thrombosis. Modifiable risk factors, such as line site, size, and lumens, were not significantly associated with thrombosis. No thromboembolic events were observed.
CONCLUSIONS: We observed a lower incidence rate of catheter-associated venous thrombosis than in most previous reports. No modifiable characteristics altered the risk of thrombosis. Additional investigation of measures to prevent thrombosis is warranted in higher-risk populations, such as patients undergoing dialysis or patients with inflammatory bowel disease.
Thank you to our partners for supporting IVTEAM